Torrent Pharmaceuticals Complete Financial Statements

TORNTPHARM • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015

Complete Financial Data Export

Export complete financial statements for Torrent Pharmaceuticals (TORNTPHARM). Downloads include all available records across all periods. For market performance, see the TORNTPHARM stock price today .

Profitability Ratios

Net Profit Margin 18.36% 2025 data
EBITDA Margin 30.66% 2025 data
Operating Margin 31.00% 2025 data
Return on Assets 3.94% 2025 data
Return on Equity 7.79% 2025 data

Balance Sheet Ratios

Current Ratio 2.10 2025 data
Debt to Equity 1.97 2025 data
Equity Ratio 50.64% 2025 data
Asset Turnover 0.21 2025 data

Year-over-Year Growth Analysis

Comparing Sept 2024 vs Sept 2025
Revenue Growth
+14.4%
Year-over-Year
Net Profit Growth
+30.5%
Year-over-Year
EBITDA Growth
+14.1%
Year-over-Year
Expense Growth
+14.5%
Year-over-Year
Assets Growth
-0.5%
Year-over-Year
Equity Growth
+10.7%
Year-over-Year
Liabilities Growth
-0.5%
Year-over-Year
Operating Cash Flow Growth
-20.9%
Year-over-Year
Investing Cash Flow Growth
-243.1%
Year-over-Year
Financing Cash Flow Growth
+17.3%
Year-over-Year

Income Statement

Periods ₹ Crores
Particulars Sept 2025 Mar 2025 Jun 2025 Sept 2024 Mar 2024 Jun 2024 Dec 2024 Sept 2023 Mar 2023 Jun 2023 Dec 2023 Sept 2022 Mar 2022 Jun 2022 Dec 2022 Sept 2021 Mar 2021 Jun 2021 Dec 2021 Sept 2020 Mar 2020 Jun 2020 Dec 2020 Sept 2019 Mar 2019 Jun 2019 Dec 2019 Sept 2018 Mar 2018 Jun 2018 Dec 2018 Sept 2017 Mar 2017 Jun 2017 Dec 2017 Sept 2016 Mar 2016 Jun 2016 Dec 2016 Sept 2015 Mar 2015 Jun 2015 Dec 2015
Revenue 3,219 2,891 3,091 2,815 2,726 2,839 2,795 2,654 2,461 2,582 2,746 2,277 2,160 2,322 2,449 2,154 1,954 2,160 2,142 1,991 1,927 2,018 1,980 2,002 1,839 1,996 1,977 1,868 1,708 1,861 1,951 1,467 1,485 1,453 1,508 1,449 1,501 1,539 1,463 1,728 1,234 1,961 1,573
Expenses 2,232 2,019 2,146 1,950 1,862 1,955 1,895 1,835 1,764 1,800 1,863 1,612 2,055 1,635 1,767 1,477 1,355 1,457 1,570 1,382 1,398 1,395 1,388 1,464 1,740 1,481 1,426 1,421 1,344 1,395 1,490 1,088 1,139 1,077 1,104 1,099 1,016 1,114 1,127 976 992 1,035 1,118
EBITDA 987 872 945 865 864 884 900 819 697 782 883 665 105 687 682 677 599 703 572 609 529 623 592 538 99 515 551 447 364 466 461 379 346 376 404 350 485 425 336 752 242 926 455
Operating Profit Margin % 31.00% 31.00% 31.00% 31.00% 31.00% 31.00% 31.00% 30.00% 28.00% 29.00% 31.00% 29.00% 2.00% 29.00% 28.00% 30.00% 29.00% 31.00% 25.00% 30.00% 27.00% 31.00% 30.00% 26.00% 5.00% 25.00% 26.00% 24.00% 19.00% 24.00% 24.00% 22.00% 18.00% 20.00% 23.00% 22.00% 31.00% 26.00% 20.00% 41.00% 13.00% 45.00% 26.00%
Depreciation 204 201 201 198 203 197 199 201 196 191 213 163 162 155 193 168 165 165 167 165 168 161 167 163 160 160 163 152 151 150 156 84 97 80 94 69 63 68 73 59 60 57 59
Interest 48 56 56 64 80 75 57 91 107 103 80 69 57 55 102 71 73 68 62 92 102 102 91 116 123 122 111 126 121 122 133 51 58 56 80 51 38 49 48 48 47 55 43
Profit Before Tax 791 665 738 661 631 656 691 559 433 531 631 463 -87 532 419 472 383 484 357 384 293 402 357 296 -150 279 319 205 134 232 275 272 244 266 259 253 410 346 245 681 155 875 377
Tax 200 167 190 208 182 199 188 173 146 153 188 151 31 178 127 156 59 154 108 74 -21 81 60 52 2 63 68 26 -94 69 29 68 38 78 201 46 126 54 16 172 25 225 87
Net Profit 591 498 548 453 449 457 503 386 287 378 443 312 -118 354 292 316 324 330 249 310 314 321 297 244 -152 216 251 179 228 163 246 204 206 188 58 207 284 292 229 509 130 650 290
Earnings Per Share (₹) 17.54 14.71 16.19 13.37 13.27 13.51 14.88 11.39 8.48 11.18 13.10 9.22 -6.97 20.90 8.63 18.63 19.16 19.53 14.75 18.32 18.56 18.98 17.52 14.48 -8.95 12.74 14.77 10.57 13.55 9.66 14.50 12.07 12.17 11.08 3.37 12.25 16.82 17.28 13.47 30.01 7.70 38.40 17.19

Related Pages for Torrent Pharmaceuticals

Additional stock information and data for TORNTPHARM

TORNTPHARM stock price chart
TORNTPHARM intrinsic value
TORNTPHARM institutional holdings
TORNTPHARM share price data
TORNTPHARM earnings multiple
TORNTPHARM earnings report
TORNTPHARM enterprise value

Balance Sheet

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 14,990 15,061 15,012 13,100 14,075 14,010 14,121 14,243 9,702 9,058 7,904
Current Assets 5,623 5,612 5,314 5,165 5,522 4,979 5,038 5,262 4,880 4,688 4,051
Fixed Assets 7,947 8,138 8,122 6,423 7,065 7,533 7,748 7,855 3,688 2,859 2,833
Capital Work in Progress 478 361 765 630 889 712 617 647 520 1,042 678
Investments 156 173 199 226 181 2 353 492 804 780 298
Other Assets 6,409 6,389 5,926 5,821 5,940 5,763 5,403 5,249 4,691 4,378 4,095
LIABILITIES
Total Liabilities 14,990 15,061 15,012 13,100 14,075 14,010 14,121 14,243 9,702 9,058 7,904
Current Liabilities 2,682 2,779 3,367 2,732 3,346 3,732 4,231 4,418 2,613 2,278 2,589
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 7,591 6,856 6,198 5,953 5,837 4,823 4,724 4,623 4,351 3,495 2,491
Share Capital 169 169 169 85 85 85 85 85 85 85 85
Reserves & Surplus 7,422 6,687 6,029 5,868 5,753 4,739 4,640 4,538 4,266 3,410 2,406

Cash Flow Statement

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities 2,585 3,266 2,368 1,803 2,005 1,393 1,798 894 1,009 2,742 810
Investing Activities -549 -160 -2,335 -196 -444 229 -246 -4,677 -798 -870 -2,113
Financing Activities -2,298 -2,780 77 -1,781 -1,651 -1,549 -1,314 3,417 -193 -1,435 1,212
Net Cash Flow -262 327 110 -174 -89 73 238 -366 18 438 -90